Aggressive breast cancer leads to discrepant serum levels of the type I procollagen propeptides PINP and PICP

• Published in: Cancer research (Chicago, Ill.) Vol. 57; no. 24; pp. 5517 - 5520
• Main Authors: JUKKOLA, A, TÄHTELÄ, R, THÖLIX, E, VUORINEN, K, BLANCO, G, RISTELI, L, RISTELI, J
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA American Association for Cancer Research 15.12.1997
• Subjects: Alkaline Phosphatase - blood; Biological and medical sciences; Bone Neoplasms - blood; Bone Neoplasms - secondary; Breast Neoplasms - blood; Breast Neoplasms - pathology; Collagen - metabolism; Cross-Sectional Studies; Disease Progression; Female; Gynecology. Andrology. Obstetrics; Humans; Mammary gland diseases; Medical sciences; Peptide Fragments - blood; Procollagen - blood; Sensitivity and Specificity; Tumors; Antineoplastic agent; Human; Alkaline phosphatase; Biological fluid; C terminal peptide; Enzyme; Phosphoric monoester hydrolases; Esterases; Malignant tumor; N terminal peptide; Blood; Mammary gland diseases; Collagen; Cross sectional study; Tumor progression; Hydrolases; Advanced stage; Serum; Mammary gland
• ISSN: 0008-5472; 1538-7445

The propeptides PICP and PINP are derived from the synthesis of type I collagen, a major matrix protein of bone and soft tissues. The aim of this cross-sectional study was to investigate their value as indicators of the aggressivity of breast cancer. Serum PINP, PICP, and total alkaline phosphatase were determined from 89 breast cancer patients. Forty had major bone and/or soft tissue metastases with an aggressive disease course: the progressive disease (PD) group. Forty-nine had either none or minor bone and/or soft tissue metastases with a stable clinical course: the stable disease group (SD). The mean value of PINP in the PD group was 7.2 times higher than that in the SD group (276 +/- 79 microg/l versus 38 +/- 3 microg/l, respectively; P = 0.005), whereas PICP mean value was only 1.7 times higher in the PD group (174 +/- 20 microg/l versus 100 +/- 5 microg/l; P = 0.001). The ratio of PICP to PINP was 1.02 +/- 0.07 in the PD group and 3.07 +/- 0.18 in the SD group (P < 0.001). The correlation between PICP and PINP was linear in the SD group and nonlinear in the PD group. The results indicate that high serum PICP and PINP concentrations and a low PICP:PINP ratio are associated with a highly aggressive nature of breast cancer. Determination of PINP, in particular, may be valuable when evaluating the clinical status of a breast cancer patient.